Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2021-03-15 Management Reports
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
2020年度董事会工作报告
Management Reports Classification · 95% confidence The document is titled '2020 年度董事会工作报告' which translates to '2020 Annual Board of Directors Work Report'. It contains detailed information about the company's operational performance, financial results for the year 2020, board meeting summaries, committee activities, profit distribution plans, and plans for 2021. The content is comprehensive and includes financial figures, governance activities, and strategic plans, indicating it is a detailed management report rather than a brief announcement or a simple voting result. The document length is 5833 characters, which is sufficient to contain substantive financial and operational data. The focus on the board's work and detailed financial and operational review aligns with the definition of a Management Reports (MDA) filing, which includes management's detailed explanation of financial results, business trends, and outlook. It is not an Annual Report (10-K) as it lacks the full financial statements and statutory disclosures typical of such filings. It is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains the full report text, not just an announcement. Therefore, the best classification is Management Reports (MDA).
2021-03-15 Chinese
非经营性资金占用及其他关联资金往来情况的专项报告
Audit Report / Information Classification · 95% confidence The document is a special report on non-operating fund occupation and other related party fund transactions for Tianjin Ruipu Biotechnology Co., Ltd. It includes audited financial data for the year 2020 and references an audit report issued on March 14, 2021. The document is prepared according to regulatory requirements from the China Securities Regulatory Commission and other authorities. It contains detailed financial tables and is signed by the accounting firm and company representatives. The document is not a full annual report but a standalone audit-related report focusing on specific financial compliance and related party transactions. It matches the description of an Audit Report / Information (AR) as it is a standalone audit report with accounting principles and related financial data, not a full annual report or other category. FY 2020
2021-03-15 Chinese
2020年内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2020 by Tianjin Ruipu Biotechnology Co., Ltd. It discusses the company's internal control evaluation, including financial and non-financial internal control effectiveness, defect identification, and remediation measures. The content is detailed and includes specific evaluation criteria, regulatory references, and corrective actions. It is not a full annual report or earnings release but a standalone report focused on internal control evaluation, which aligns with the definition of an Audit Report / Information (AR). The document length (6391 characters) and detailed content confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2020
2021-03-15 Chinese
关于会计政策变更公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding a change in accounting policy related to the adoption of a new lease accounting standard effective from January 1, 2021. It details the reasons for the change, the approval process by the board and supervisory committee, and the impact on financial statements. The document is relatively short (2042 characters) and serves as a formal disclosure of the accounting policy change rather than a full financial report or audit report. It does not contain actual financial statements or detailed financial data but rather informs stakeholders about the policy change and related approvals. Therefore, it fits best as a Regulatory Filing (RNS) since it is a regulatory announcement about accounting policy changes without substantive financial data or full report content.
2021-03-15 Chinese
2020年年度报告（已取消）
Annual Report Classification · 100% confidence The document is titled as the "2020 年年度报告全文" which translates to "2020 Annual Report Full Text" for Tianjin Ringpu Biotechnology Co., Ltd. It contains detailed sections typical of an annual report, including company overview, financial data, business summary, risk disclosures, governance, and financial statements. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content includes audited financial figures, management discussion and analysis, and detailed business operations, all consistent with an official annual report. There is no indication that this is merely an announcement or a certification document. Therefore, the document fits the definition of an Annual Report (10-K). FY 2020
2021-03-15 Chinese
2020年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2020 年度业绩快报' which translates to '2020 Annual Performance Express Report' or '2020 Annual Earnings Quick Report'. It contains preliminary financial data for the year 2020, including revenue, profit, net profit, earnings per share, and asset information. The document explicitly states that the data is preliminary and unaudited, and that the final detailed financial data will be disclosed in the 2020 Annual Report. The document is relatively short (2536 characters) and serves as an initial earnings announcement rather than a full annual report. It includes key financial highlights and performance analysis but does not contain full financial statements or comprehensive analysis typical of a full Annual Report (10-K). Therefore, this document fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. FY 2020
2021-03-01 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.